Associated Papers
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK et al.
Molecular Cancer, 2021
34044846 (PubMed )
Supplement: 12943_2021_1377_MOESM2_ESM.zip › Additional_file_2-Table_S3.xlsx › non-silent_mutations_and_indel
Select a paper to view details